Table 2: Decision for a method comparison trial in the new region (Xc = 150 cells/μL × 103).

Δ

P new P

ρ

Decision New Region

Proportion of Subjects for Bridging Study

Sample Size for Bridging Study

1

1.000

0.92

No Clinical Trial

.

.

2

0.999

0.85

No Clinical Trial

.

.

3

0.996

0.77

No Clinical Trial

.

.

4

0.984

0.70

No Clinical Trial

.

.

5

0.955

0.62

No Clinical Trial

.

.

6

0.894

0.54

Bridging Study

0.09

18

7

0.783

0.47

New Clinical Trial

.

.

8

0.637

0.39

New Clinical Trial

.

.

9

0.460

0.32

New Clinical Trial

.

.

10

0.292

0.24

New Clinical Trial

.

.

11

0.159

0.16

New Clinical Trial

.

.

12

0.074

0.09

New Clinical Trial

.

.